Header Logo

Connection

JOSEPH JANKOVIC to Dystonia

Back to Details
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Dystonia.
JOSEPH JANKOVIC
Connection Strength
12.537
Dystonia
  1. Is Dystonia an Immunologic Disorder? Parkinsonism Relat Disord. 2024 May; 122:106084.
    View in: PubMed
    Score: 0.745
  2. Sports-Related Dystonia. Tremor Other Hyperkinet Mov (N Y). 2021; 11:54.
    View in: PubMed
    Score: 0.640
  3. Botulinum Neurotoxin Injections in Childhood Opisthotonus. Toxins (Basel). 2021 02 12; 13(2).
    View in: PubMed
    Score: 0.603
  4. Functional (psychogenic) saccadic oscillations and oculogyric crises. Lancet Neurol. 2016 07; 15(8):791.
    View in: PubMed
    Score: 0.438
  5. Dopa-responsive dystonia--clinical and genetic heterogeneity. Nat Rev Neurol. 2015 Jul; 11(7):414-24.
    View in: PubMed
    Score: 0.408
  6. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up. Toxicon. 2014 Nov; 90:344-8.
    View in: PubMed
    Score: 0.384
  7. Treatment of dystonia. Neurotherapeutics. 2014 Jan; 11(1):139-52.
    View in: PubMed
    Score: 0.368
  8. Medical treatment of dystonia. Mov Disord. 2013 Jun 15; 28(7):1001-12.
    View in: PubMed
    Score: 0.355
  9. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel). 2013 Feb 04; 5(2):249-66.
    View in: PubMed
    Score: 0.346
  10. Parkinsonism and dystonia associated with adalimumab. Mov Disord. 2011 Jul; 26(8):1556-8.
    View in: PubMed
    Score: 0.305
  11. Hemidystonia-hemiatrophy syndrome. Mov Disord. 2009 Mar 15; 24(4):583-9.
    View in: PubMed
    Score: 0.264
  12. Genetic study of an American family with DYT3 dystonia (lubag). Neurosci Lett. 2008 Dec 26; 448(2):180-3.
    View in: PubMed
    Score: 0.257
  13. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease. Expert Rev Neurother. 2007 Jun; 7(6):637-47.
    View in: PubMed
    Score: 0.233
  14. Treatment of dystonia. Parkinsonism Relat Disord. 2007; 13 Suppl 3:S362-8.
    View in: PubMed
    Score: 0.227
  15. Treatment of dystonia. Lancet Neurol. 2006 Oct; 5(10):864-72.
    View in: PubMed
    Score: 0.223
  16. Globus pallidus deep brain stimulation in dystonia. Mov Disord. 2006 May; 21(5):692-5.
    View in: PubMed
    Score: 0.216
  17. Dystonia and other deformities in Parkinson's disease. J Neurol Sci. 2005 Dec 15; 239(1):1-3.
    View in: PubMed
    Score: 0.208
  18. The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry. 2005 Sep; 76(9):1188-93.
    View in: PubMed
    Score: 0.207
  19. Definition and Classification of Dystonia. Mov Disord. 2025 Jul; 40(7):1248-1259.
    View in: PubMed
    Score: 0.202
  20. Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord. 2005 May; 20(5):592-7.
    View in: PubMed
    Score: 0.202
  21. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry. 2004 Jul; 75(7):951-7.
    View in: PubMed
    Score: 0.191
  22. Dystonia: medical therapy and botulinum toxin. Adv Neurol. 2004; 94:275-86.
    View in: PubMed
    Score: 0.184
  23. Longitudinal predictors of health-related quality of life in isolated dystonia. J Neurol. 2024 Feb; 271(2):852-863.
    View in: PubMed
    Score: 0.181
  24. Tourettism and dystonia after subcortical stroke. Mov Disord. 2002 Jul; 17(4):821-5.
    View in: PubMed
    Score: 0.166
  25. Dystonia in spinocerebellar ataxia type 6. Mov Disord. 2002 Jan; 17(1):150-3.
    View in: PubMed
    Score: 0.160
  26. Dystonia and parkinsonism. Parkinsonism Relat Disord. 2001 Oct; 8(2):109-21.
    View in: PubMed
    Score: 0.158
  27. Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusion. Eur J Neurol. 2021 12; 28(12):3999-4009.
    View in: PubMed
    Score: 0.156
  28. Dystonia in corticobasal degeneration. Mov Disord. 2001 Mar; 16(2):252-7.
    View in: PubMed
    Score: 0.151
  29. Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort. Neurology. 2021 01 26; 96(4):e563-e574.
    View in: PubMed
    Score: 0.147
  30. Clinical and Demographic Characteristics of Upper Limb Dystonia. Mov Disord. 2020 11; 35(11):2086-2090.
    View in: PubMed
    Score: 0.146
  31. Functional gait disorders, clinical phenomenology, and classification. Neurol Sci. 2020 Apr; 41(4):911-915.
    View in: PubMed
    Score: 0.139
  32. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology. 1999 Dec 10; 53(9):2102-7.
    View in: PubMed
    Score: 0.139
  33. Bruxism and cranial-cervical dystonia: is there a relationship? Cranio. 1999 Jul; 17(3):196-201.
    View in: PubMed
    Score: 0.135
  34. Dystonia. Nat Rev Dis Primers. 2018 09 20; 4(1):25.
    View in: PubMed
    Score: 0.128
  35. Medical therapy and botulinum toxin in dystonia. Adv Neurol. 1998; 78:169-83.
    View in: PubMed
    Score: 0.122
  36. Hemidystonia secondary to carotid artery gunshot injury. Childs Nerv Syst. 1997 May; 13(5):285-8.
    View in: PubMed
    Score: 0.116
  37. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl. 1997; 6:S129-45.
    View in: PubMed
    Score: 0.113
  38. Examiner manoeuvres 'sensory tricks' in functional (psychogenic) movement disorders. J Neurol Neurosurg Psychiatry. 2017 05; 88(5):453-455.
    View in: PubMed
    Score: 0.113
  39. "Complex" dystonia is not a category in the new 2013 consensus classification. Mov Disord. 2016 11; 31(11):1758-1759.
    View in: PubMed
    Score: 0.111
  40. Cervical dystonia as the initial presentation of Huntington's disease. Mov Disord. 1996 Jul; 11(4):457-9.
    View in: PubMed
    Score: 0.109
  41. Response and immunoresistance to botulinum toxin injections. Neurology. 1995 Sep; 45(9):1743-6.
    View in: PubMed
    Score: 0.103
  42. Botulinum toxin in the treatment of dystonic tics. Mov Disord. 1994 May; 9(3):347-9.
    View in: PubMed
    Score: 0.094
  43. Reply: dystonia after severe head injuries. Mov Disord. 2014 Apr; 29(4):578-9.
    View in: PubMed
    Score: 0.093
  44. Designing clinical trials for dystonia. Neurotherapeutics. 2014 Jan; 11(1):117-27.
    View in: PubMed
    Score: 0.092
  45. Use of botulinum toxin in the treatment of hand dystonia. J Hand Surg Am. 1993 Sep; 18(5):883-7.
    View in: PubMed
    Score: 0.090
  46. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013 Jun 15; 28(7):863-73.
    View in: PubMed
    Score: 0.088
  47. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology. 1993 Apr; 43(4):834-6.
    View in: PubMed
    Score: 0.087
  48. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon. 2013 Jun 01; 67:94-114.
    View in: PubMed
    Score: 0.086
  49. Acoustic reflex abnormalities in cranial-cervical dystonia. Neurology. 1992 Mar; 42(3 Pt 1):594-7.
    View in: PubMed
    Score: 0.081
  50. Persistent dystonia possibly induced by flecainide. Mov Disord. 1992; 7(1):62-3.
    View in: PubMed
    Score: 0.080
  51. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 2012 Jan 26; 1(1):2-12.
    View in: PubMed
    Score: 0.080
  52. Clinical correlates of response to botulinum toxin injections. Arch Neurol. 1991 Dec; 48(12):1253-6.
    View in: PubMed
    Score: 0.080
  53. Pain in Parkinson's disease. Mov Disord. 2012 Apr; 27(4):485-91.
    View in: PubMed
    Score: 0.079
  54. The coexistence of tics and dystonia. Arch Neurol. 1991 Aug; 48(8):862-5.
    View in: PubMed
    Score: 0.078
  55. Cervical dystonia: clinical findings and associated movement disorders. Neurology. 1991 Jul; 41(7):1088-91.
    View in: PubMed
    Score: 0.077
  56. Dystonic tics in patients with Tourette's syndrome. Mov Disord. 1991; 6(3):248-52.
    View in: PubMed
    Score: 0.075
  57. Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord. 2010 Dec; 16(10):628-38.
    View in: PubMed
    Score: 0.073
  58. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. 1990 Aug; 53(8):633-9.
    View in: PubMed
    Score: 0.073
  59. Botulinum toxin injections for cervical dystonia. Neurology. 1990 Feb; 40(2):277-80.
    View in: PubMed
    Score: 0.070
  60. Sulpiride-induced tardive dystonia. Mov Disord. 1990; 5(1):83-4.
    View in: PubMed
    Score: 0.070
  61. Peripherally induced movement disorders. Neurol Clin. 2009 Aug; 27(3):821-32, vii.
    View in: PubMed
    Score: 0.068
  62. Dystonia in musicians. Semin Neurol. 1989 Jun; 9(2):131-5.
    View in: PubMed
    Score: 0.067
  63. Dystonia and tremor induced by peripheral trauma: predisposing factors. J Neurol Neurosurg Psychiatry. 1988 Dec; 51(12):1512-9.
    View in: PubMed
    Score: 0.065
  64. Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A. Neurology. 2008 Sep 23; 71(13):1040; author reply 1040-1.
    View in: PubMed
    Score: 0.064
  65. Focal task-specific tremor and dystonia: categorization of occupational movement disorders. Neurology. 1988 Apr; 38(4):522-7.
    View in: PubMed
    Score: 0.062
  66. Tardive dystonia in patients with Tourette's syndrome. Mov Disord. 1988; 3(3):274-80.
    View in: PubMed
    Score: 0.061
  67. Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy. Adv Neurol. 1988; 50:583-91.
    View in: PubMed
    Score: 0.061
  68. Hemiparkinsonism-hemiatrophy syndrome. Neurology. 2007 Oct 16; 69(16):1585-94.
    View in: PubMed
    Score: 0.060
  69. Genetics of essential tremor. Brain. 2007 Jun; 130(Pt 6):1456-64.
    View in: PubMed
    Score: 0.057
  70. Drug-induced dystonia in neuronal ceroid-lipofuscinosis. Pediatr Neurol. 1986 Jul-Aug; 2(4):236-7.
    View in: PubMed
    Score: 0.055
  71. Camptocormia: pathogenesis, classification, and response to therapy. Neurology. 2005 Aug 09; 65(3):355-9.
    View in: PubMed
    Score: 0.051
  72. Essential tremor among children. Pediatrics. 2004 Nov; 114(5):1203-5.
    View in: PubMed
    Score: 0.049
  73. Comparison of thalamotomy and pallidotomy for the treatment of dystonia. Neurosurgery. 2001 Apr; 48(4):818-24; discussion 824-6.
    View in: PubMed
    Score: 0.038
  74. Can peripheral trauma induce dystonia and other movement disorders? Yes! Mov Disord. 2001 Jan; 16(1):7-12.
    View in: PubMed
    Score: 0.037
  75. Pallidotomy for generalized dystonia. Mov Disord. 1998 Jul; 13(4):693-8.
    View in: PubMed
    Score: 0.031
  76. Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response. Neurology. 1998 Jun; 50(6):1624-9.
    View in: PubMed
    Score: 0.031
  77. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections. Mov Disord. 1998 Jan; 13(1):150-4.
    View in: PubMed
    Score: 0.030
  78. Symptomatic and functional outcome of surgical treatment of cervical dystonia. J Neurol Neurosurg Psychiatry. 1997 Nov; 63(5):642-8.
    View in: PubMed
    Score: 0.030
  79. Familial essential tremor in 4 kindreds. Prospects for genetic mapping. Arch Neurol. 1997 Mar; 54(3):289-94.
    View in: PubMed
    Score: 0.029
  80. Thalamic surgery for movement disorders. Adv Neurol. 1997; 74:221-33.
    View in: PubMed
    Score: 0.028
  81. Outcome after stereotactic thalamotomy for dystonia and hemiballismus. Neurosurgery. 1995 Mar; 36(3):501-7; discussion 507-8.
    View in: PubMed
    Score: 0.025
  82. Post-traumatic movement disorders: central and peripheral mechanisms. Neurology. 1994 Nov; 44(11):2006-14.
    View in: PubMed
    Score: 0.024
  83. Sensory aspects of movement disorders. Lancet Neurol. 2014 Jan; 13(1):100-12.
    View in: PubMed
    Score: 0.023
  84. Tardive stereotypy and other movement disorders in tardive dyskinesias. Neurology. 1993 May; 43(5):937-41.
    View in: PubMed
    Score: 0.022
  85. Cocaine-related movement disorders. Mov Disord. 1993 Apr; 8(2):175-8.
    View in: PubMed
    Score: 0.022
  86. Intrathecal baclofen for intractable axial dystonia. Neurology. 1991 Jul; 41(7):1141-2.
    View in: PubMed
    Score: 0.019
  87. Therapeutic uses of botulinum toxin. N Engl J Med. 1991 Apr 25; 324(17):1186-94.
    View in: PubMed
    Score: 0.019
  88. Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J. 1990 May; 83(5):525-32.
    View in: PubMed
    Score: 0.018
  89. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology. 1988 Mar; 38(3):391-4.
    View in: PubMed
    Score: 0.015
  90. Cranial-cervical dyskinesias: an overview. Adv Neurol. 1988; 49:1-13.
    View in: PubMed
    Score: 0.015
  91. Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain. 2006 Sep; 129(Pt 9):2318-31.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.